Five membered heterocyclic rings possessing a mixture of different heteroatoms like S, N, O, etc. not only possess interesting chemical properties but also have a myriad number of biological activities. Of these, 1,3,4-thiadiazole moiety and its derivatives have gained a deep interest in recent year due to their crucial role in wide variety of drugs, dyes, and other substances of high interests. The present work is focussed on the different methods of their synthesis. The review highlights the key features of their synthesis.
Introduction
I. INTRODUCTION
Heterocyclic organic compounds are those that have heteroatoms like O, N, S, or P as one of the ring members. Modern organic chemistry includes the chemistry of heterocyclic compounds as a fundamental component. One of the most important factors that determines a heterocyclic molecule's physical characteristics, reactivity, and ease of synthesis is its ring size. The most common and dominant class of heterocyclic compounds contains those with heterocyclic rings made of nitrogen, oxygen, and sulphur. There are many heterocyclic compounds with rings containing three to six carbons, but five and six membered rings are by far the most significant. Thiophene, furan, and pyrrole are the three most basic and extensively researched single heteroatoms with five membered heterocyclic rings. Azole, thiazole, thiadiazole, oxadiazole, etc. are examples of five-membered rings that contain two or more heteroatoms. A five-membered ring having two or more heteroatoms, one of which being Nitrogen, is described by the suffix -azole.
Due to their distinct chemical characteristics and diverse biological activities, heterocyclic rings and their many derivatives have garnered the majority of chemists' attention in recent years. These rings have also found applications in the chemical and pharmaceutical industries. Despite tremendous advancements in the study of heterocyclic ring systems, work is still being done to find new heterocyclic compounds that have strong bioactivities. Numerous heterocyclic compounds, including imidazole, oxazole, thiazole, oxadiazole, and thiadiazole, have been the subject of research. These molecules frequently have biological effects. In the past, the thiadiazole ring has been used to bind substances like antiparasitic and antibacterial agents, and some of the resulting medicines are still in use today [1-3]. Recent studies have shown that the thiadiazole ring is a significant structural element with wide-ranging biological action.
Thiadiazole and its derivatives have received attention of researchers due to ease of synthesis, stability and wide spectrum of biological applications. Thiadiazole is a five membered heterocyclic ring system containing one sulphur and two nitrogen atoms. Thiadiazoles are derivatives of thiophene, formed by replacing the two –CH= (methine) groups by pyridine-type nitrogen (-N=).
The numbering of monocyclic azole system commences with the heteroatom from highest group in the periodic table with the element of lowest atomic number in same group. Consequently, the numbering of 1,3,4-thiadiazole 4 is done in the following manner. This designated that one sulphur atom is present in the ring.
Conclusion
1,3,4-thiadiazole and its derivatives are prepared by a variety of methods and reaction conditions. In general, different Lewis’s acids like POCl3, PPA dry ZnCl2, etc. are commonly employed to get a good yield of 1,3,4-thiadiazole and its derivatives. Their role is highly crucial as dehydrating or cyclizing agents. The present work offered an insightful understanding of synthesis of 1,3,4-thiadiazole and its derivatives.
References
[1] Kumar, D., Kumar N. M., Chang, K. H., Shah, K., Eur. J. Med. Chem. 2010, 45, 4664–4668.
[2] Wadher, S. J., Puranik, M. P., Karande, N. A., and Yeole, P. G., International Journal of Pharm Tech Research. 2009, 1(1), 22-33.
[3] Rajavel, R., Vadivu, M. S., and Anitha, C., E-Journal of Chem. 2008, 5(3), 620-626.
[4] de Andrade Danin Barbosa, G., & Palermo de Aguiar, A. (2019). Synthesis of 1,3,4-Thiadiazole Derivatives and Microbiological Activities: A Review. Revista Virtual de Química, 11(3), 806-848. doi: 10.21577/1984-6835.20190058
[5] Rühlmann, K. (1959). Über die Synthese von 1,3,4-Thiadiazolidinen und 1,3,4-Thiadiazolen. Journal für Praktische Chemie, 8(5-6), 285-291. doi: 10.1002/prac.19590080505.
[6] Oruç, E. E., Rollas, S., Kandemirli, F., Shvets, N., & Dimoglo, A. S. (2004). 1,3,4-Thiadiazole Derivatives. Synthesis, Structure Elucidation, and Structure?Antituberculosis Activity Relationship Investigation. Journal of Medicinal Chemistry, 47(27), 6760-6767. doi: 10.1021/jm0495632.
[7] Hoggarth, E. (1950). 116. Compounds related to thiosemicarbazide. Part IV. 5-Amino-3-phenyl-1:2:4-triazoles. Journal of the Chemical Society (Resumed), 612. doi: 10.1039/jr9500000612.
[8] Fromm, E., Layer, E., & Nerz, K. (1923). Abkömmlinge von Thio-semicarbaziden und Hydrazo-dithio-dicarbonamiden. Justus Liebig\'s Annalen der Chemie, 433(1), 1-17. doi: 10.1002/jlac.19234330102.
[9] Harish, K. P., Mohana, K. N., & Mallesha, L. (2013). Synthesis of Pyrazine Substituted 1,3,4-Thiadiazole Derivatives and Their Anticonvulsant Activity. Organic Chemistry International, 2013, 1-8. doi: 10.1155/2013/631723.
[10] Stolle, R. (1899). Ueber die Ueberführung der secundären Säurehydrazide in Derivate des Furodiazols, Pyrrodiazols und Thiodiazols. Berichte der deutschen chemischen Gesellschaft, 32(1), 797-798.
[11] Kokovina, T. S., Gadomsky, S. Y., Terentiev, A. A., & Sanina, N. A. (2021). A Novel Approach to the Synthesis of 1,3,4-Thiadiazole-2-amine Derivatives. Molecules, 26(17), 5159. doi: 10.3390/molecules26175159.
[12] F. Kurzer, J. Canell, Tetrahed, 1963, 19, 1603-1610.
[13] Guha, P. C. (1922). Constitution of theso-calleddithiourazole of Martin Freund. J. Am. Chem. Soc., 44, 1502-1510.
[14] Sahu, S., Sahu, T., Kalyani, G., & Gidwani, B. (2021). Synthesis and Evaluation of Antimicrobial Activity of 1, 3, 4-Thiadiazole Analogues for Potential Scaffold. Journal of Pharmacopuncture, 24(1), 32-40. doi: 10.3831/kpi.2021.24.1.32.
[15] Kurzer, F., & Wilkinson, M. (1970). Heterocyclic compounds from urea derivatives. Part XVII. Reactions of 1-phenylcarbonohydrazide and 1-phenylthiocarbonohydrazide with carbodi-imides. Journal of the Chemical Society C: Organic(1), 26. doi: 10.1039/j39700000026.
[16] Almasirad, A., Firoozpour, L., Nejati, M., Edraki, N., Firuzi, O., Khoshneviszadeh, M., . . . Foroumadi, A. (2016). Design, synthesis, and biological evaluation of new series of 2-amido-1,3,4-thiadiazole derivatives as cytotoxic agents. Zeitschrift für Naturforschung B, 71(3), 205-210. doi: 10.1515/znb-2015-0138.
[17] C. S. Mahajanshetti, V. T. Udapudi, J. Oil Technol. Assoc. India, 1984, 18 (2), 52.
[18] Hegab, M., & Shamroukh, A. (2020). A Review on Synthesis, Therapeutic, and Computational Studies of Substituted 1, 3, 4 Thiadiazole Derivatives. Egyptian Journal of Chemistry, 0(0), 0-0. doi: 10.21608/ejchem.2020.25343.2492.
[19] Esmail, R., & Kurzer, F. (1977). Chemistry of biureas—II. Tetrahedron, 33(15), 2007-2012. doi: 10.1016/0040-4020(77)80392-x.
[20] Young, G., & Eyre, W. (1901). III.—Oxidation of benzalthiosemicarbazone. J. Chem. Soc., Trans., 79(0), 54-60. doi: 10.1039/ct9017900054.
[21] Kalluraya, B. (2018). Synthesis and Characterization of Novel Series of 1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazole Derivatives of Anilinoacetic Acids as Promising Antioxidant Agents. Archives of Organic and Inorganic Chemical Sciences, 2(2). doi: 10.32474/aoics.2018.02.000135.
[22] Bhargava, K. K., Lee, M. H., Huang, Y.-M., Cunningham, L. S., Agrawal, K. C., & Sartorelli, A. C. (2002). Tetramisole analogs as inhibitors of alkaline phosphatase, an enzyme involved in the resistance of neoplastic cells to 6-thiopurines. Journal of Medicinal Chemistry, 20(4), 563-566. doi: 10.1021/jm00214a021
[23] Turner, S., Myers, M., Gadie, B., Hale, S. A., Horsley, A., Nelson, A. J., . . . Berridge, T. L. (2002). Antihypertensive thiadiazoles. 2. Vasodilator activity of some 2-aryl-5-guanidino-1,3,4-thiadiazoles. Journal of Medicinal Chemistry, 31(5), 906-913. doi: 10.1021/jm00400a004.
[24] Skrzypek, A., Matysiak, J., Niewiadomy, A., Bajda, M., & Szyma?ski, P. (2013). Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors. European Journal of Medicinal Chemistry, 62, 311-319. doi: 10.1016/j.ejmech.2012.12.060.
[25] S. J. Collier, Methoden der Organischen Chemie, (Houben-Weyl) Science of Synthesis, R. C. Storr and T. L. Gilehrist. Eds. Thieme., 2004, 13-349.
[26] Amir, M., Kumar, H., & Javed, S. A. (2008). Condensed bridgehead nitrogen heterocyclic system: Synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid. European Journal of Medicinal Chemistry, 43(10), 2056-2066. doi: 10.1016/j.ejmech.2007.09.025.
[27] Shen, H. C., Ding, F.-X., & Colletti, S. L. (2006). ?-Heteroarylation of Esters, Lactones, Amides, and Lactams by Nucleophilic Aromatic Substitution. Org Lett, 8(7), 1447-1450. doi: 10.1021/ol060246u.
[28] Akhter, M. W., Hassan, M. Z., & Amir, M. (2014). Synthesis and pharmacological evaluation of 3-diphenylmethyl-6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles: A condensed bridgehead nitrogen heterocyclic system. Arabian Journal of Chemistry, 7(6), 955-963. doi: 10.1016/j.arabjc.2014.05.036.
[29] Amir, M., Kumar, H., & Javed, S. A. (2007). Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen. Bioorganic & Medicinal Chemistry Letters, 17(16), 4504-4508. doi: 10.1016/j.bmcl.2007.06.003
[30] Jayaweera, G. D. S. A., MacNeil, S. A., Trager, S. F., & Blackburn, G. M. (1991). Synthesis of 2-substituted-1,3,4-thiadiazole-5-sulphonamides as novel water-soluble inhibitors of carbonic anhydrase. Bioorganic & Medicinal Chemistry Letters, 1(8), 407-410. doi: 10.1016/s0960-894x(00)80266-8
[31] Demirbas, N. (2005). Synthesis and Characterization of New Triheterocyclic Compounds Consisting of 1,2,4-Triazol-3-one, 1,3,4-Thiadiazole and 1,3,4-Oxadiazole Rings. Turk. J. Chem., 29, 125 -133.
[32] S. Turner, M. Myers, B. Gadie, A. J. Nelson, R. Pape, J F. Saville, T. L. Berridge, J. Med. Chem., 1988, 31(5), 902-906.
[33] K. Shrivastava, S. Purohit, S. Singhal, Asian J. Biomed. Pharm. Sci., 2013, 3, 6-23.